
|Videos|August 4, 2021
From Drug Substance to Drug Product: Integrated Solid Form Selection
Author(s)Lonza
What are some effective strategies for compressing development timelines and derisking the process along the way? The PharmTech-Lonza Tech Talks Series on Integrated Services includes a 12-minute discussion of integrated drug substance form selection and optimization to drug product with Michael Grass, PhD, head of solid form services at Lonza.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Lilly Invests $3.5B in Pennsylvania Injectable Medicine Facility
2
Navigating the Complex Risks of Accelerated Pharmaceutical Launches
3
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5




